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I
n the United States, a generation 
and more has passed since 
widespread sustained political 
involvement by students in the affairs 
of the nation, such as the movement 
to oppose the war in Vietnam. Today’s 
students and post-doctoral fellows 
have no first-hand memory of broad, 
organized efforts to convince the 
government that represents them to 
shift its priorities significantly. This 
has presented a special challenge to 
ensuring the continued vigor of the 
biomedical research enterprise. Why 
should scientists invest precious time to 
advocate for biomedical research?
Today, political involvement by 
scientists is widely acknowledged to be 
vital for the continued health of the 
biomedical research enterprise. Science 
must inform important national policy 
issues such as genetically modified 
foods, animal research, the teaching 
of evolution, and stem cell research. 
Experience has shown that when public 
debate is not grounded in fact, pseudo-
science fills the vacuum. Also, while 
federal support for basic biomedical 
research is per se uncontroversial and 
enjoys broad bipartisan support, in a 
difficult economy, when tradeoffs must 
be made in discretionary spending, 
there is an urgency to explain and 
promote the importance of basic 
research and its contributions to 
human health. Members of Congress 
are elected, at least theoretically, for 
their judgment, their experience, and 
their principles. No one individual, no 
matter how competent, can be deeply 
informed about every sector of the 
economy over which she has control 
as legislator and appropriator. Thus, 
members of Congress rely on those 
with special expertise to educate them. 
To be sure, there are professionals 
in Washington whose full-time 
concern is advocating for biomedical 
research. Why shouldn’t the work 
of educating Congress be left in 
the hands of these advocates? First, 
because notwithstanding their passion 
and the merit of the interest they 
represent, professional advocates 
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can be perceived, by members of 
Congress without sophisticated 
appreciation of biomedical research, 
as just another lobbyist, little different 
than one from the National Wooden 
Pallet & Container Association or 
the Snack Food Association. Second, 
only researchers themselves can 
credibly convey the full excitement, 
promise, and potential of scientific 
research from their own experience. 
Third, scientists who talk to their 
representative or senator have 
particular influence when they are 
themselves constituents or when 
they come from institutions that 
are important employers in the 
representative’s district. Fourth, there 
is power in numbers: the voices for 
biomedical science must be a steady 
stream in the ear of Congress. Fifth, 
establishing communication between 
representatives or their health staffs 
and the scientist-constituent provides 
a point of contact should an issue 
emerge that requires the representative 
to seek advice about a biomedical 
research matter. 
Advocacy battles must be fought 
on multiple fronts. The fundamental 
issue that never goes away is funding. 
Congress has been supportive of 
biomedical research in the last 
several years: over the course of two 
administrations and congressional 
majorities of both parties, leaders have 
come together to double the budget 
of the National Institutes of Health 
(NIH) over five years, concluding in 
2003. Similarly, the National Science 
Foundation is enjoying special support 
at the current time. But, as any scientist 
who visits Capitol Hill can testify, the 
number of dollars appropriated for 
biomedical research is just one of 
several issues of concern to members 
of Congress, to patients and their 
advocates, and to researchers alike.
Scientists, like other citizens, 
recognize that there are multiple 
legitimate priorities for federal 
support. Inevitable conflicts among 
spending priorities can leave a 
scientist ambivalent about advocacy 
for increased funding for biomedical 
research, potentially at the cost of
other worthy programs. But other 
worthy programs are promoted by 
those who are expert in them, as 
scientists are experts in research. The 
jobs of those experts are to advocate for 
education, law enforcement, housing, 
etc., as scientists advocate for research. 
In Washington, federally supported 
programs that are not constantly 
promoted will lose support to those 
that are.
The more complicated, more 
political, and more polarizing issues 
that we grapple with include embryonic 
stem cell research, somatic cell nuclear 
transfer, even the teaching of natural 
selection in public schools. Those who 
are opposed to these activities are well 
organized and well financed. They 
reach elected representatives and voters 
at every level, from the White House to 
the local school board. Scientists have 
a moral obligation to respond to and 
preempt ideological demands and to 
ensure that federal policy decisions are 
based on sound fact and science.
A coalition of scientific societies was 
organized by the American Society for 
Cell Biology in 1989 under the name 
of The Joint Steering Committee for 
Public Policy (JSC). It was founded by 
scientists who saw the need to become 
involved in the political process. The 
scientific community is fortunate that 
JSC leadership includes many of the 
country’s most respected scientists. 
Among its activities, the JSC  helped 
Congress launch the Congressional 
Biomedical Research Caucus, which 
has since grown to become perhaps the 
most credible caucus in Congress. A 
caucus serves a convening, organizing, 
and advocacy function for members of 
Congress who support its purpose: a 
sort of bipartisan, no-dues association 
for congressional representatives. Like 
the Congressional Black Caucus or the 
Congressional Women’s Caucus, the 
Congressional Biomedical Research 
Caucus is most centrally concerned 
with federal funding. Among its 
activities is a highly successful series of 
briefings that brings research leaders 
to Capitol Hill to describe the latest 
advances in biomedical research. 
Nearly 125 such briefings have 
been hosted by the caucus since the 
founding of the JSC.
The JSC also founded the 
Congressional Liaison Committee 
(CLC) to enable every biomedical 
scientist to engage in the political 
process. Any scientist who cares 
about the future of basic research 
is encouraged to participate in the 
activities of the CLC. Multiple levels of 
involvement are available, from signing 
a pre-drafted letter to a member of 
Congress to traveling to Washington, 
D.C., to spend a day meeting with 
congresspersons and their staffs. 
Advocacy can be just as effective 
at home: when in recess in their 
district, House representatives often 
welcome an invitation to visit a lab 
or an assembly of scientists. Scientists 
at any point in their education and 
career are welcome—a representative 
often favors a post-doc from her own 
district to a world-renowned scientist 
from someone else’s. CLC staff 
thoroughly brief participants on issues 
and protocol for participating in the 
political process and accompany the 
delegation of scientists on its visits. 
The JSC and the scientific societies it 
represents face formidable immediate 
challenges. Chief among them is to 
ensure a level of NIH funding into the 
future that maximizes the potential to 
capitalize on past federal investment 
in research. Scientists also share 
responsibility to support continued 
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wise management and priority-setting 
by NIH leadership: NIH director Elias 
Zerhouni recently released a plan 
to support new collaborations and 
ensure that human benefits are derived 
from scientific discovery—the result 
of extended consultation with the 
scientific community.
The culture and progress of 
science require contributions by 
every individual beyond the success 
of her own experiments: reviewing 
papers, serving on study sections, 
recommending accomplished 
colleagues for awards or promotion, 
serving as a mentor to students and 
junior scientists. To that we must add 
communicating with our members 
of Congress about the importance 
of basic biomedical research. It is 
easy to be complacent when one’s 
research is funded and one’s career is 
progressing—but such complacency is 
no more advisable than closing down 
the local fire station because your 
own house is not burning. As those 
of us who remember an earlier era of 
political involvement know, if you’re 
not part of the solution, you’re part of 
the problem. 
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